FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366823019> ?p ?o ?g. }

• W4366823019 abstract "The coronavirus disease 2019 (COVID-19) outbreak, which first appeared in the Chinese province of Hubei city of Wuhan, has been spreading internationally since December 2019. The World Health Organization (WHO) declared the coronavirus illness from 2019 to be a pandemic on March 11, 2020. Patients hospitalised with severe coronavirus or comorbid conditions (like cardiovascular disease and obesity) are linked to a worse prognosis. The rise in D-dimer and its relationship to prognosis are the most often documented aberrations in coagulation/fibrinolysis in COVID-19. However, the D-dimer assessment's utility is not limitless. Since the coagulation/fibrinolytic state might occasionally change over a short period of time, routine exams are also advantageous in understanding the relevance of the inquiry. Both thrombotic and hemorrhagic diseases should be taken into consideration, despite the fact that the pathophysiology of disseminated intravascular coagulation (DIC) linked with coronavirus disease 19 differs significantly from that of septic disseminated intravascular coagulation. Coagulation as well as fibrinolysis indicators are used to make the diagnosis of COVID-19 thrombosis, which encompasses both macro- and micro-thrombosis. Compared to bacterial-sepsis-associated coagulopathy/DIC, COVID-19 has a lower prevalence of prolonged prothrombin time, activated partial thromboplastin time, and decreased antithrombin activity. However, the causes of coagulopathy remain poorly understood. Hypoxia, endothelial injury, dysregulated immunological responses mediated by inflammatory cytokines, and lymphocyte cell death are thought to be implicated. While blood loss tends to be rare, it is uncertain if COVID-19 suffers from thrombosis or whether the current recommendations for regular venous thromboembolic dose are appropriate. It is important to decide on the COVID-19 therapy phases. Antiviral therapy, cytokine storm therapy, and thrombosis therapy are the steps. Future advancements are predicted, such as a therapy that combines heparin and nafamostat." @default.
• W4366823019 created "2023-04-25" @default.
• W4366823019 creator A5022440868 @default.
• W4366823019 creator A5023327278 @default.
• W4366823019 creator A5071533098 @default.
• W4366823019 date "2023-04-24" @default.
• W4366823019 modified "2023-10-05" @default.
• W4366823019 title "Common Coagulopathies Associated With COVID-19 Patients" @default.
• W4366823019 cites W1526693451 @default.
• W4366823019 cites W1666433089 @default.
• W4366823019 cites W1828216453 @default.
• W4366823019 cites W2007539022 @default.
• W4366823019 cites W2108927671 @default.
• W4366823019 cites W2130450914 @default.
• W4366823019 cites W2131262274 @default.
• W4366823019 cites W2371232026 @default.
• W4366823019 cites W2470646526 @default.
• W4366823019 cites W3001118548 @default.
• W4366823019 cites W3004280078 @default.
• W4366823019 cites W3007643904 @default.
• W4366823019 cites W3008394341 @default.
• W4366823019 cites W3008461878 @default.
• W4366823019 cites W3008827533 @default.
• W4366823019 cites W3009885589 @default.
• W4366823019 cites W3010126769 @default.
• W4366823019 cites W3011072970 @default.
• W4366823019 cites W3011127849 @default.
• W4366823019 cites W3011610993 @default.
• W4366823019 cites W3012421327 @default.
• W4366823019 cites W3013302817 @default.
• W4366823019 cites W3013630838 @default.
• W4366823019 cites W3014233146 @default.
• W4366823019 cites W3014281460 @default.
• W4366823019 cites W3015656121 @default.
• W4366823019 cites W3015863623 @default.
• W4366823019 cites W3016406354 @default.
• W4366823019 cites W3017326650 @default.
• W4366823019 cites W3020301027 @default.
• W4366823019 cites W3020710323 @default.
• W4366823019 cites W3021787050 @default.
• W4366823019 cites W3022187628 @default.
• W4366823019 cites W3022564719 @default.
• W4366823019 cites W3023560309 @default.
• W4366823019 cites W3024193040 @default.
• W4366823019 cites W3025781472 @default.
• W4366823019 cites W3028615142 @default.
• W4366823019 cites W3031456278 @default.
• W4366823019 cites W3033285830 @default.
• W4366823019 cites W3036512428 @default.
• W4366823019 cites W3040268873 @default.
• W4366823019 cites W3041582510 @default.
• W4366823019 cites W3042508286 @default.
• W4366823019 cites W3047913942 @default.
• W4366823019 cites W3080487846 @default.
• W4366823019 cites W3091820618 @default.
• W4366823019 cites W3093214735 @default.
• W4366823019 cites W3096640075 @default.
• W4366823019 cites W3097903491 @default.
• W4366823019 cites W4243658067 @default.
• W4366823019 doi "https://doi.org/10.7759/cureus.38067" @default.
• W4366823019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37234147" @default.
• W4366823019 hasPublicationYear "2023" @default.
• W4366823019 type Work @default.
• W4366823019 citedByCount "0" @default.
• W4366823019 crossrefType "journal-article" @default.
• W4366823019 hasAuthorship W4366823019A5022440868 @default.
• W4366823019 hasAuthorship W4366823019A5023327278 @default.
• W4366823019 hasAuthorship W4366823019A5071533098 @default.
• W4366823019 hasBestOaLocation W43668230191 @default.
• W4366823019 hasConcept C126322002 @default.
• W4366823019 hasConcept C177713679 @default.
• W4366823019 hasConcept C203014093 @default.
• W4366823019 hasConcept C2776825266 @default.
• W4366823019 hasConcept C2777557582 @default.
• W4366823019 hasConcept C2778261982 @default.
• W4366823019 hasConcept C2778382381 @default.
• W4366823019 hasConcept C2778384902 @default.
• W4366823019 hasConcept C2778734968 @default.
• W4366823019 hasConcept C2779026020 @default.
• W4366823019 hasConcept C2779036427 @default.
• W4366823019 hasConcept C2779519742 @default.
• W4366823019 hasConcept C2779936836 @default.
• W4366823019 hasConcept C2780011451 @default.
• W4366823019 hasConcept C2780434524 @default.
• W4366823019 hasConcept C2780868729 @default.
• W4366823019 hasConcept C71924100 @default.
• W4366823019 hasConceptScore W4366823019C126322002 @default.
• W4366823019 hasConceptScore W4366823019C177713679 @default.
• W4366823019 hasConceptScore W4366823019C203014093 @default.
• W4366823019 hasConceptScore W4366823019C2776825266 @default.
• W4366823019 hasConceptScore W4366823019C2777557582 @default.
• W4366823019 hasConceptScore W4366823019C2778261982 @default.
• W4366823019 hasConceptScore W4366823019C2778382381 @default.
• W4366823019 hasConceptScore W4366823019C2778384902 @default.
• W4366823019 hasConceptScore W4366823019C2778734968 @default.
• W4366823019 hasConceptScore W4366823019C2779026020 @default.
• W4366823019 hasConceptScore W4366823019C2779036427 @default.
• W4366823019 hasConceptScore W4366823019C2779519742 @default.
• W4366823019 hasConceptScore W4366823019C2779936836 @default.
• W4366823019 hasConceptScore W4366823019C2780011451 @default.

• next